The emergence and spread of SARS-CoV-2 lineage B.1.1.7, first detected in the United
Kingdom, has become a global public health concern because of its increased transmissibility. …

Background The prognosis of patients with recurrent World Health Organization (WHO) grade
IV malignant glioma is dismal, and there is currently no effective therapy. We conducted a …

We have developed a clinically validated NGS assay that includes tumor, germline and RNA
sequencing. We apply this assay to clinical specimens and cell lines, and we demonstrate …

Several immunotherapy clinical trials in recurrent glioblastoma have reported long-term
survival benefits in 10–20% of patients. Here we perform genomic analysis of tumor tissue from …

Gastric cancer remains difficult to cure and has a poor overall prognosis. Chemotherapy and
multimodality therapy has shown some benefit in the treatment of gastric cancer. Current …

Cell-lineage-specific transcription factors are a group of regulatory proteins expressed in
embryonic, differentiated, or neoplastic cells of the same lineage and represent a valuable …

Genomic analysis of paired tumor–normal samples and clinical data can be used to match
patients to cancer therapies or clinical trials. We analyzed 500 patient samples across diverse …

Background Homologous recombination deficiency (HRD) is a phenotype that is
characterized by the inability of a cell to effectively repair DNA double-strand breaks using the …

While identifying genomic alterations in tumor tissue is the current gold-standard technique
for molecular profiling, circulating tumor DNA (ctDNA) represents a noninvasive method of …

We developed and clinically validated a hybrid capture next generation sequencing assay
to detect somatic alterations and microsatellite instability in solid tumors and hematologic …